Skip to content
DataLookout
Menu

NCT07155590

Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 15 words
    • Trial completed
    • Collaborators: details revised at 1 of 4 entries
    • Publications: details revised at 1 of 1 entry
  2. Minor Site details revised at 1 of 2 sites
    • Study title shortened, about 6 words
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

All-cause mortality at 60 days
Timeframe: At 60 days from randomisation

Secondary (2)

All-cause mortality at 30 days
Treatment success at 8 weeks

Arms and interventions

Adjunctive fosfomycin therapy

Patients with Staphylococcus aureus bacteraemia from the BACSAFO cohort treated with any regimen including fosfomycin

Monotherapy

Patients with Staphylococcus aureus bacteraemia from the BACSAFO cohort treated with any regimen not containing fosfomycin

Sites

2 sites in 1 country